Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/35159| Title: | Antibacterial prophylaxis for neutropenic and high-risk hematology patients-Do the benefits outweigh the risk? | Austin Authors: | Reynolds, Gemma;Lindsay, Julian | Affiliation: | Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Infectious Diseases |
Issue Date: | 8-Mar-2024 | Date: | 2024 | Publication information: | Transplant infectious disease : an official journal of the Transplantation Society 2024-04; 26(2) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/35159 | DOI: | 10.1111/tid.14255 | ORCID: | 0000-0002-7086-538X | Journal: | Transplant Infectious Disease : an Official Journal of the Transplantation Society | Start page: | e14255 | PubMed URL: | 38459753 | ISSN: | 1399-3062 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.